The structural integrity of meningococcal native, micro-fluidized and activated capsular polysaccharides and their glycoconjugates – in the form most relevant to their potential use as vaccines (dilute solution) - have been investigated with respect to their homogeneity, conformation and flexibility. Sedimentation velocity analysis showed that the polysaccharide size distributions were generally bimodal with some evidence for higher molar mass forms at higher concentration. Weight average molar masses Mw where lower for activated polysaccharides. Conjugation with tetanus toxoid protein however greatly increased the molar mass and polydispersity of the final conjugates. Glycoconjugates had an approximately unimodal log-normal but broad and l...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that causes recurrent...
The capsular polysaccharide is the main virulence factor in meningococcus. The capsular polysacchari...
<i>Neisseria meningitidis</i> type A (MenA) is a Gram-negative encapsulated bacterium that is a majo...
The structural integrity of meningococcal native, micro-fluidized and activated capsular polysacchar...
Three important physical properties which may affect the performance of glycoconjugate vaccines agai...
AbstractAn analysis of structure-antibody recognition relationships in nine licenced polysaccharide-...
A vaccine to prevent infections from the emerging Neisseria meningitidis X (MenX) is becoming an urg...
Neisseria meningitidis is a leading cause of severe bacterial infections in infants and young childr...
Tetanus toxoid protein has been characterized with regard oligomeric state and hydrodynamic (low-res...
Neisseria meningitidis can cause severe and fulminant diseases such as meningitis. Meningococcal cap...
Neisseria meningitidis serogroup A (MenA) is an aerobic diplococcal Gram-negative bacterium responsi...
Vaccination is the most cost-effective way to control disease caused by encapsulated bacteria; the c...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Background. Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that causes recurrent...
The capsular polysaccharide is the main virulence factor in meningococcus. The capsular polysacchari...
<i>Neisseria meningitidis</i> type A (MenA) is a Gram-negative encapsulated bacterium that is a majo...
The structural integrity of meningococcal native, micro-fluidized and activated capsular polysacchar...
Three important physical properties which may affect the performance of glycoconjugate vaccines agai...
AbstractAn analysis of structure-antibody recognition relationships in nine licenced polysaccharide-...
A vaccine to prevent infections from the emerging Neisseria meningitidis X (MenX) is becoming an urg...
Neisseria meningitidis is a leading cause of severe bacterial infections in infants and young childr...
Tetanus toxoid protein has been characterized with regard oligomeric state and hydrodynamic (low-res...
Neisseria meningitidis can cause severe and fulminant diseases such as meningitis. Meningococcal cap...
Neisseria meningitidis serogroup A (MenA) is an aerobic diplococcal Gram-negative bacterium responsi...
Vaccination is the most cost-effective way to control disease caused by encapsulated bacteria; the c...
Synthesis of Neisseria meningitidis serogroup A carba analogues as hydrolytically stable antigens fo...
Background. Group A Neisseria meningitidis has been a major cause of bacterial meningitis in the sub...
N. meningitidis type X (Men X), first described in the 1960s1, has been found to cause a few cases o...
Neisseria meningitidis type A (MenA) is a Gram-negative encapsulated bacterium that causes recurrent...
The capsular polysaccharide is the main virulence factor in meningococcus. The capsular polysacchari...
<i>Neisseria meningitidis</i> type A (MenA) is a Gram-negative encapsulated bacterium that is a majo...